X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (420) 420
Publication (46) 46
Newspaper Article (24) 24
Patent (17) 17
Book Chapter (8) 8
Book Review (8) 8
Book / eBook (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (240) 240
hematology (167) 167
index medicus (161) 161
female (144) 144
male (140) 140
middle aged (122) 122
multiple myeloma (122) 122
aged (121) 121
multiple myeloma - drug therapy (104) 104
oncology (97) 97
bortezomib (90) 90
adult (75) 75
multiple myeloma - therapy (70) 70
antineoplastic combined chemotherapy protocols - therapeutic use (68) 68
prognosis (68) 68
multiple myeloma - mortality (65) 65
therapy (64) 64
stem-cell transplantation (60) 60
survival (58) 58
treatment outcome (56) 56
aged, 80 and over (53) 53
multiple myeloma - pathology (50) 50
thalidomide (46) 46
care and treatment (43) 43
multiple myeloma - diagnosis (43) 43
abridged index medicus (40) 40
disease-free survival (39) 39
transplantation, autologous (39) 39
disease progression (35) 35
recurrence (35) 35
survival analysis (34) 34
transplantation (33) 33
antineoplastic agents - therapeutic use (32) 32
chemotherapy (32) 32
dexamethasone (32) 32
follow-up studies (30) 30
survival rate (30) 30
boronic acids - administration & dosage (29) 29
pyrazines - administration & dosage (29) 29
risk factors (29) 29
hematology, oncology and palliative medicine (28) 28
monoclonal gammopathy (28) 28
multiple myeloma - genetics (28) 28
remission induction (28) 28
boronic acids - therapeutic use (26) 26
hematopoietic stem cell transplantation (26) 26
lenalidomide (26) 26
multiple-myeloma (26) 26
pyrazines - therapeutic use (26) 26
dexamethasone - administration & dosage (25) 25
melphalan (25) 25
multiple myeloma - complications (24) 24
myeloma (24) 24
diagnosis (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (22) 22
melphalan - administration & dosage (22) 22
thalidomide - therapeutic use (22) 22
cancer (21) 21
high-dose therapy (21) 21
autologous transplantation (20) 20
criteria (19) 19
hemic and lymphatic diseases (19) 19
lenalidomide plus dexamethasone (19) 19
medicine, general & internal (19) 19
prednisone - administration & dosage (19) 19
progression (19) 19
research (19) 19
stem cell transplantation (19) 19
thalidomide - administration & dosage (19) 19
thalidomide - analogs & derivatives (19) 19
biochemistry (18) 18
chemistry (18) 18
kaplan-meier estimate (18) 18
minimal residual disease (18) 18
multiple myeloma - blood (18) 18
prednisone (18) 18
time factors (18) 18
doxorubicin - administration & dosage (17) 17
elderly-patients (17) 17
metallurgy (17) 17
organic chemistry (17) 17
stem cells (17) 17
undetermined significance (17) 17
antineoplastic agents - administration & dosage (16) 16
boronic acids - adverse effects (16) 16
drug administration schedule (16) 16
leukemia (16) 16
multiple myeloma - immunology (16) 16
pyrazines - adverse effects (16) 16
relapse (16) 16
wine (16) 16
beer (15) 15
bone-marrow (15) 15
compositions thereof (15) 15
culture media (15) 15
dexamethasone - therapeutic use (15) 15
enzymology (15) 15
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (15) 15
foods or foodstuffs (15) 15
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (15) 15
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (460) 460
Spanish (11) 11
French (6) 6
German (5) 5
Finnish (3) 3
Swedish (3) 3
Portuguese (2) 2
Catalan (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 438 - 447
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 934 - 941
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2006, Volume 355, Issue 26, pp. 2765 - 2770
A 58-year-old man with no significant medical history is found to have an elevated total protein concentration (8.1 g per deciliter) on a routine blood... 
Case studies | Monoclonal gammopathies | Proteins | Plasma | Medical diagnosis | Age
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1551 - 1560
Summary Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs.... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | RISK | MULTICENTER | THERAPY | ELOTUZUMAB | Drug Administration Schedule | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Spain | Canada | Disease-Free Survival | Multiple Myeloma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Drugs | Medical colleges | Biological products | Multiple myeloma | Monoclonal antibodies | Product development | Lymphomas | Drug therapy | Care and treatment | Analysis | Studies | Protease inhibitors | Hematology | Stem cells | Cytotoxicity | Patients | Drug dosages | Slopes | Therapy | Schedules | Intravenous administration | Stem cell transplantation | Transplantation | Drug screening | Immunosuppressive agents | Randomization | CD38 antigen | Autografts | Anemia | Immunomodulation | Research & development--R&D | FDA approval | Survival | Proteasome inhibitors | Asthma | Refractory materials | Inhibitors | Interactive systems | Response rates
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article